FDA drug approval summary: bevacizumab plus interferon for advanced renal cell carcinoma (Q35583662)
Jump to navigation
Jump to search
scientific article published on 8 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA drug approval summary: bevacizumab plus interferon for advanced renal cell carcinoma |
scientific article published on 8 January 2010 |
Statements
1 reference
FDA drug approval summary: bevacizumab plus interferon for advanced renal cell carcinoma (English)
1 reference
Jeff Summers
1 reference
Martin H Cohen
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
8 January 2010
1 reference
1 reference
1 reference
Identifiers
1 reference